Perigon Wealth Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,147
Closed -$409K 282
2018
Q3
$409K Buy
+2,147
New +$394K 0.1% 136
2018
Q2
Sell
-14,290
Closed -$2.4M 662
2018
Q1
$2.4M Sell
14,290
-160
-1% -$26.8K 0.89% 33
2017
Q4
$2.36M Sell
14,450
-795
-5% -$143K 0.88% 35
2017
Q3
$3.12M Buy
15,245
+14
+0.1% +$3.26K 1.01% 26
2017
Q2
$3.7M Sell
15,231
-9
-0.1% -$2.12K 0.81% 34
2017
Q1
$3.64M Hold
15,240
0.77% 35
2016
Q4
$3.74M Sell
15,240
-5,020
-25% -$1.04M 0.82% 32
2016
Q3
$4.67M Buy
20,260
+105
+0.5% +$25.7K 1.2% 19
2016
Q2
$4.66M Buy
+20,155
New +$4.65M 1.24% 15
2016
Q1
Sell
-20,055
Closed -$6.27M 334
2015
Q4
$6.27M Buy
20,055
+160
+0.8% +$47.6K 1.73% 11
2015
Q3
$5.41M Sell
19,895
-515
-3% -$158K 1.6% 10
2015
Q2
$6.19M Sell
20,410
-226
-1% -$67.4K 1.63% 9
2015
Q1
$6.14M Buy
20,636
+326
+2% +$92.9K 1.68% 9
2014
Q4
$5.23M Sell
20,310
-560
-3% -$140K 1.57% 11
2014
Q3
$5.04M Buy
20,870
+11
+0.1% +$2.46K 1.5% 11
2014
Q2
$4.65M Buy
20,859
+4
+0% +$828 1.33% 15
2014
Q1
$4.29M Hold
20,855
2.36% 7
2013
Q4
$3.5M Buy
+20,855
New +$3.26M 1.94% 12

Other funds holding AGN

Perigon Wealth Management's AGN Position: Q4 2018 in Review

Perigon Wealth Management sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 2,147 shares — an estimated $409K sold.

Perigon Wealth Management first reported a position in AGN in Q4 2013 and held it in 18 quarters. The position peaked at $6.27M in Q4 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Perigon Wealth Management reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Perigon Wealth Management sold 2,147 Allergan plc shares in Q4 2018, an estimated $409K.
  • Perigon Wealth Management first reported a position in Allergan plc in Q4 2013 and held it in 18 quarters.
  • Perigon Wealth Management's Allergan plc position peaked at $6.27M in Q4 2015.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Perigon Wealth Management's 13F filing for Q4 2018, filed 11 Feb 2019.